Frovatriptan succinate hydrate
CAS: 158930-17-7
Ref. TM-T11326
2mg | 35,00 € | ||
5mg | 52,00 € | ||
10mg | 87,00 € | ||
25mg | 142,00 € | ||
50mg | 204,00 € | ||
100mg | 301,00 € | ||
1ml*10 (DMSO) | 59,00 € |
Información del producto
- Frovelan, Frova
- (3R)-2,3,4,9-Tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide Butanedioic Acid Monohydrate
- Frovatriptan Succinate Monohydrate
- Frovelan
- Migard
- (3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide
Frovatriptan succinate hydrate (Frova) is effective in treating the full spectrum of migraine including the associated symptoms of nausea, vomiting, photophobia, and phonophobia. Frovatriptan succinate hydrate can also be used as in mini-prophylaxis in menstrual migraine. Frovatriptan succinate hydrate is a potent, high affinity, selective and orally active 5-HT1B, HT1D receptor agonist and a moderately potent 5-HT7 receptor agonist, with pKi values of 8.6, 8.4, and 6.7, respectively.
Propiedades químicas
Consulta técnica sobre: TM-T11326 Frovatriptan succinate hydrate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.